Granulocyte colony-stimulating factor, granulocyte-macrophage colony- stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia

Leukemia Research

Volumn 22, Issue 12, 1998, Pages 1143-1154

  Ohno, Ryuzo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Macrophage colony stimulating factor

Indexed keywords

ASPARAGINASE; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; ENOCITABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MERCAPTOPURINE; MITOXANTRONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032423381     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00117-9     Document Type: Article

References (62)

1. Ohno R. Current progress in the treatment of adult acute leukemia in Japan. Jpn J Clin Oncol. 22:1993;85-97.
2. Berman E. Chemotherapy in acute myelogenous leukemia: high dose, higher expectation? J Clin Oncol. 13:1995;1-4.
3. Groopman J.E., Molina J.-M., Scadden D.T. Hematopoietic growth factors: Biology and clinical applications. New Engl J Med. 321:1989;1449-1459.
4. Antman K.S., Griffin J.D., Elias A., Socinski M.A., Ryan L., Cannistra S.A., Oette D., Whitley M., Frei E. III, Schnipper L.E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. New Engl J Med. 319:1988;593-598.
5. Masaoka T., Shibata H., Ohno R., Katoh S., Harada M., Motoyoshi K., Takaku F., Sakuma A. Double-blind test of human urinary macrophage colony-stimulating factor for allogeneic and syngeneic bone marrow transplantation: effectiveness of treatment and 2-year follow-up for relapse of leukaemia. Br J Haematol. 76:1990;501-505.
6. Sheridan W.P., Morstyn G., Wolf M.et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. ii:1989;891-895.
7. Souza L.M., Boone T.C., Gabrilove J.L.et al. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science. 232:1986;61-65.
8. Griffin J.D., Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 68:1986;1185-1195.
9. Vellenga E., Young D.C., Wagner K., Wiper D., Ostapovicz D., Griffin J.D. The effect of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood. 69:1987;1771-1776.
10. Vellenga E., Ostapovicz D., O'Rourke B., Griffin J.D. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia. 1:1987;584-589.
11. Asano Y., Okamura S., Shibuya T., Harada M., Niho Y. Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood. 72:1988;1682-1686.
12. Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Clark S., Löwenberg B. Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood. 72:1988;1944-1949.
13. Löwenberg B., Salem M., Delwel R. Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells. 14:1988;539-549.
14. Miyauchi J., Kelleher C.A., Wong G.G., Yang Y., Clark S.C., Minkin S., Minden M.D., McCulloch E.A. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. Leukemia. 2:1988;382-387.
15. Motoji T., Takanashi M., Fuchinoue M., Masuda M., Oshimi K., Mizoguchi H. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. Exp Hematol. 17:1989;56-60.
16. Park L.S., Waldron P.E., Friend D.et al. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood. 74:1989;56-65.
17. Inoue C., Hotta T., Murate T., Saito H. Response of leukemic cells to the sequential combination of GM-CSF and G-CSF. Int J Cell Biol. 8:1990;54-62.
18. Lemoli R.M., Gulati S.C., Strife A., Lambek C., Perez A., Clarkson B.D. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia. 5:1991;386-391.
19. Ohno R. G-CSF in the treatment of acute myeloid leukemia: Is it safe? Leukemia Lymph. 11:1993;5-19.
20. Harousseau J.L., Wu D. The Use of GM-CSF and G-CSF in the treatment of acute leukemia. Leukemia Lymph. 18:1995;405-412.
21. Geller R.B. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review. J Clin Oncol. 14:1996;1371-1382.
22. Rowe J.M., Liesveld J.L. Hematopoietic growth factors in acute leukemia. Leukemia. 11:1997;328-341.
23. Johnson P.R.E., Liu Yin J.A. Annotation: The role of granulocyte- and granulocyte-macrophage-colony-stimulating factors in the treatment of acute myeloid leukaemia. Br J Haematol. 97:1997;1-8.
24. Terpstra W., Löwenberg B. Application of myeloid growth factors in the treatment of acute myeloid leukemia. Leukemia. 11:1997;315-327.
25. Ohno R., Tomonaga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A.B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia: A randomized controlled study. New Engl J Med. 323:1990;871-877.
26. Büchner T., Hiddemann W., Koenigsmann M., Zuhlsdorf M., Wormann B., Boeckmann A., Freire E.A., Innig G., Maschmeyer G., Ludwig W.D. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood. 78:1991;1190-1197.
27. Rowe J.M., Andersen J.W., Mazza J.J., Bennett J.M., Paietta E., Hayes F.A., Oette D., Cassileth P.A., Stadtmauer E.A., Wiernik P.H. A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490). Blood. 86:1995;457-462.
28. Stone R.M., Berg D.T., George S.L., Dodge R.K., Paciucci P.A., Schulman P., Lee E.J., Moore J.O., Powell B.L., Schiffer C.A. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia (for the Cancer and Leukemia Group B). New Engl J Med. 332:1995;1671-1677.
29. Zittoun R., Suciu S., Mandelli F., de Witte T., Thaler J., Stryckmans P., Hayat M., Peetermans M., Cadiou M., Solbu G., Petti M.C., Willemze R. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: A randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. J Clin Oncol. 14:1996;2150-2159.
30. Dombret H., Chastang C., Fenaux P., Reiffers J., Bordessoule D., Bouabdallah R., Mandelli F., Ferrant A., Auzanneau G., Tilly H., Yver A., Degos L. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia (for the AML Cooperative study group). New Engl J Med. 332:1995;1678-1683.
31. Godwin J.E., Kopecky K.J., Head D.R., Hynes H.E., Balcerzak S.P., Appelbaum F.R. A double blind placebo controlled trial of G-CSF in elderly patients with previously untreated acute myeloid leukemia. A Southwest Oncology Group study. Blood. 86(Suppl 1 (abstract)):1995;434a.
32. Shimoda K., Okamura S., Harada N., Ikematsu W., Kondo S., Kawasaki C., Tanaka T., Etou T., Akashi K., Okamura T., Shibuya T., Harada M., Niho Y. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors. Cancer Res. 52:1992;3052-3055.
33. Shinjo K., Takeshita A., Ohnishi K., Ohno R. Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leukemia Lymph. 25:1997;37-46.
34. Budel L.M., Touw I.P., Delwel R., Löwenberg B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood. 74:1989;2668-2673.
35. Motoji T., Watanabe M., Uzumaki H., Kusaka M., Fukamachi H., Shimosaka A., Oshimi K., Mizoguchi H. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay. Br J Haematol. 77:1991;54-59.
36. Ohno R., Tomonaga M., Ohshima T., Masaoka T., Asou N., Oh H., Nishikawa K., Kanamaru A., Murakami H., Furusawa S., Hirano M., Tsubaki K., Imai K., Ueda T., Kuraishi Y., Ogawa N. A randomized controlled study of granulocyte-colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia (Japan Adult Leukemia Study Group). Int J Hematol. 58:1993;73-81.
37. Ottmann O.J., Hoelzer D., Gracien E., Ganser A., Kelly K., Reutzel R., Lipp T., Busch F.W., Schwonzen M., Heil G., Wandt H., Koch P., Kolbe K., Heyll A., Bentz M., Peters S., Diedrich H., Dethling J., Meyer P., Nowrousian M.R., Löffler B., Weiss A., Kneba M., Föller A., Graf M., Hecht T. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase III trial. Blood. 86:1995;444-450.
38. Welte K., Reiter A., Mempel K., Pfetsch M., Schwab G., Schrappe M., Riehm H. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia (On behalf of the Berlin-Frankfurt-Münster Study Group). Blood. 87:1996;3143-3150.
39. Cannistra S., Groshek P., Griffin J.D. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia. 3:1989;328.
40. Tafuni A., Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia. 4:1990;826.
41. Santini V., Nooter K., Delwel R., Löwenberg B. Susceptibility of acute myeloid leukemia cells from clinically resistant and sensitive patients to daunomycin (DNR): Assessment in vitro after stimulation with colony stimulating factors. Leukemia Res. 14:1990;377.
42. Karp J., Burke P., Donehower R. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: Comparability with drug-induced humoral stimulatory activity. Leukemia. 4:1990;553.
43. Bhalla K., Birkhofer M., Arlin Z., Grant S., Lutzky J., Graham G. Effect of recombinant GM-CSF on the metabolism of cytosine-arabinoside in normal and leukemic human bone marrow cells. Leukemia. 2:1988;810.
44. Bettelheim P., Valent P., Andreeff M., Tafuri A., Haimi J., Gorischek C., Muhm M., Sillaber C.H., Haas O., Vieder L., Maurer D., Schulz G., Speiser W., Geissler K., Kier P., Hinterberger W., Lechner K. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood. 77:1991;700-711.
45. Estey E., Thall P.F., Kantarjian H.M., O'Brien S., Koller C.A., Beran M., Gutterman J., Deiserroth A., Keating M. Treatment of newly diagnosed acute myelogenous leukemia with and granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose are-C+daunorubicin: Comparison to patients treated without GM-CSF. Blood. 79:1992;2246-2255.
46. Ohno R., Naoe T., Kanamaru A., Yoshida M., Hiraoka A., Kobayashi T., Ueda T., Minami S., Morishima Y., Saito Y., Furusawa S., Imai K., Takemoto Y., Miura Y., Teshima H., Hamajima N. A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia (with the Kohseisho Leukemia Study Group). Blood. 83:1994;2086-2092.
47. Büchner T., Hiddemann W., Wörmann B., Rottmann R., Zühlsdorf M., Maschmeyer G., Ludwig W.-D., Sauerland M.C., Frisch J., Schulz G. GM-CSF multiple course priming and long-term administration in newly diagnosed AML. Hematologic and therapeutic effects (The AMLCG). Blood. 84(Suppl 1 (abstract)):1994;27a.
48. Witz F., Harousseau J.L., Sadoun A., Guyotat D., Berthou C., Cahn J.Y., Gardin C., Lioure B., Witz B., Desablens B., Ifrah N., Pignon B., Leprise P.Y., Audhuy B., Caillot D., Cassassus P., Linassier P., Christian B., Hurteloup P., Polin V., Tellier Z. GM-CSF during and after remission induction treatment for elderly patients with acute myeloid leukemia (AML) (The GOELAM Group). Blood. 86(Suppl 1 (abstract)):1995;512a.
49. Harousseau J.L., Pignon B., Witz F., Polin V., Tellier Z., Hurteloup P., Cahn J.Y. Treatment of acute myeloblastic leukemia in adults. The GOELAM experience. Hematol Cell Ther. 38:1996;381-391.
50. Heil G., Chadid L., Hoelzer D., Seipelt G., Mitrou P., Huber Ch., Kolbe K., Mertelsmann R., Lindemann A., Frisch J., Nicolay U., Gaus W., Heimpel H. GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia. 9:1995;3-9.
51. Löwenberg B., Suciu S., Zittoun R., Ossenkoppele G., Boogaerts M.A., Wijermans P., Vellenga E., Berneman Z., Dekker A.W., Sonneveld P., Stryckmans P., Solbu G., Dardenne M., De Witte Th., Archimbaud E. GM-CSF during as well as after induction chemotherapy in elderly patients with acute myeloid leukemia. Blood. 86(Suppl 1 (abstract)):1995;433a.
52. Takeshita A., Ohno R., Hirashima K., Toyama K., Okuma M., Saito H., Ikeda Y., Tomonaga M., Asano S. A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. Rinsyou-Ketsueki (Japanese with English abstract). 36:1995;606-614.
53. Moore J.O., Dodge R.K., Amrein P.C., Kolitz J., Lee E.J., Powell B., Godfrey S., Robert F., Schiffer C.A. Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B Study 9022. Blood. 89:1997;780-788.
54. Becker S., Warren M.K., Haskill S. Colony-stimulating factor induced monocyte survival and differentiation into macrophages in serum free cultures. J Immunol. 139:1987;3703-3709.
55. Ralph P., Warren M.K., Nakoinz I. Biological properties and molecular biology of the human macrophage growth factor, CSF-1. Immunobiology. 172:1986;194.
56. Karbassi A., Becker J.M., Foster J.S., Moore R.N. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J Immunol. 139:1987;417-421.
57. Hume D.A., Pavli P., Dohahue R.E., Fidler I.J. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J Immunol. 141:1988;3405-3409.
58. Ralph P., Nakoinz I. Stimulation of macrophage tumoricidal activity by CSF-1. Cell Immunol. 105:1987;270-279.
59. Suzu S., Yokota H., Yamada M., Yanai N., Saito M., Kawashima T., Saito M., Takaku F., Motoyashi K. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res. 49:1989;5913-5917.
60. Munn D.H., Cheung N.V. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med. 78:1990;907-913.
61. Ohno R, Miyawaki S, Hatake K, Kuriyama K, Saito K, Kanamaru A, Kobayashi T, Kodera Y, Nishikawa K, Matsuda S, Yamada O, Omoto E, Takeyama H, Tsukuda K, Asou N, Tanimoto M, Shiozaki H, Tomonaga M, Masaoka T, Miura Y, Takaku F, Ohashi Y, Motoyoshi K. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. J Clin Oncol 1997;15:2954-65.
62. Dorr R.T. Clinical properties of yeast-derived versus. E. coli-derived granulocyte-macrophage colony-stimulating factor. Clin Ther. 15:1993;19-29.